• A Phase 3 Study of Delgocitinib Cream to Evaluate Efficacy and Safety in Adult Women with Lichen Sclerosus

    Not yet recruiting

    3 1
    Investigated Diseases:
    France Germany Italy Poland Spain

  • Capecitabine drug combination in perioperative treatment for patients with gastric and esophageal cancer

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of Doxycycline Bone and Joint Penetration in Patients Undergoing Total Hip Arthroplasty for Hip Osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Greece Italy Spain

  • Phase 1/2 First‑in‑Human Study of Oral GSK5471713B in Adults with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    France The Netherlands Spain

  • Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Spain Sweden

  • Randomized study of ketotifen nasal spray (0.025% and 0.050%) versus sodium cromoglicate nasal spray in patients with rhinitis

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Greece

  • Fosfomycin versus drug combination for oral step‑down treatment of febrile urinary tract infections caused by E. coli in men

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of neoadjuvant intratumoral ipilimumab combined with systemic nivolumab in patients with locally advanced resectable oral cavity squamous cell carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands

powered by